Paul Ibbett
Scientist II
MiNK Therapeutics
Ann Ager
Professor of Cellular Immunity and Immunotherapy, Division of Infection and Immunity, School of Medicine and Systems Immunity Research Institute
Cardiff University
Troels Jordansen
CEO
Glycostem Therapeutics
Sven Kili
CEO
Antion Biosciences
Stuart Curbishley
Head of Business and Project Development – Advanced Therapies
University of Birmingham
Sarah Tettamanti
Postdoctoral Research Scientist
M. Tettamanti Foundation Research Center
Robert Igarashi
Head of Discovery & Pre-Clinical Development
Kiadis Pharma, a Sanofi Company
Rebecca Street-Howard
Cell and Gene Therapy Systems Director
GSK
Pedro Correa de Sampaio
CEO
Neobe Therapeutics
Olivier Negre
CSO
Smart Immune